Symptoms may develop suddenly or gradually and may include pain or stiffness in the neck or back, balance issues, or a ...

Newswatch 16's Kerry Kearns talked to a neurosurgeon at UPMC about the connection between the brain and spinal cord and when ...

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing exosome-based ...

WEST LAFAYETTE, Ind. – A brief application of a polymer commonly used in medicine and cosmetics has been shown to immediately repair damaged nerve membranes in live guinea pigs with severe spinal cord ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

Bourguignon, Lukas et al. systematically review the effect of drugs commonly administered after traumatic spinal cord injury on the neurological recovery in both animal studies and humans.

US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

Realizing a Phase I human clinical trial commencing to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury. Since the passing of ...

“Our innovative nerve bridges, combined with the high purity olfactory cells, offer what we think is the best hope for treating spinal cord injury,” Professor James St John of Griffith ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

His team has created nerve bridges from olfactory ensheathing cells, overcoming previous limitations involved in the transplantation of cells directly into the spinal cord. Professor St John said ...